Health Link Co., Ltd. (603707.SH) subsidiary received approval from the US FDA for the registration of the increase in production site for the acetyloxybutyrine injection.

Wisdom Financial APP news, Jianyou Stock (603707.SH) announced that its subsidiary Meitheal Pharmaceuticals, Inc. (referred to as Meitheal) recently received approval from the US Food and Drug Administration (FDA) to increase production sites for its acetate octreotide injection, 50 mcg/mL, 100 mcg/mL, and 500 mcg/mL (ANDA number: 075957), and approval to produce at the site of Nanjing Jianyou Biochemical Pharmaceuticals Co., Ltd.